Retatrutide is a new medication in the fight against obesity. This groundbreaking drug, belonging to a dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By stimulating these receptors, Retatrutide suppresses appetite, {promotesinsulin secretion, and ultimately leads to significant weight loss. While research is ong